Heterophile interference accounts for method-specific dsDNA antibodies in patients receiving anti-TNF treatment
To evaluate analytical explanations for the highly reported incidence of antibodies to dsDNA in patients receiving TNF antagonists. Sixty serum samples from patients receiving biological anti-TNF medication were assessed for the presence of dsDNA antibodies using three standard diagnostic platforms [ELISA, IIF and multiplex bead array (MBA)], before and after treatment to block heterophile antibodies. Results were compared with those obtained using serum samples from patients with SLE. We...[Show more]
|Collections||ANU Research Publications|
|01_Alshekaili_Heterophile_interference_2010.pdf||178.91 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.